MX2011001183A - Metodo para preparar un extracto de begazo de muscadine. - Google Patents

Metodo para preparar un extracto de begazo de muscadine.

Info

Publication number
MX2011001183A
MX2011001183A MX2011001183A MX2011001183A MX2011001183A MX 2011001183 A MX2011001183 A MX 2011001183A MX 2011001183 A MX2011001183 A MX 2011001183A MX 2011001183 A MX2011001183 A MX 2011001183A MX 2011001183 A MX2011001183 A MX 2011001183A
Authority
MX
Mexico
Prior art keywords
muscadine
bagasse
extract
bagasse extract
purple
Prior art date
Application number
MX2011001183A
Other languages
English (en)
Spanish (es)
Inventor
William J Mergens
Teodoro T Ianiro
Laurel A Fisher
Original Assignee
Shaklee Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shaklee Corp filed Critical Shaklee Corp
Publication of MX2011001183A publication Critical patent/MX2011001183A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
MX2011001183A 2008-07-31 2009-07-31 Metodo para preparar un extracto de begazo de muscadine. MX2011001183A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8537108P 2008-07-31 2008-07-31
PCT/US2009/052346 WO2010014873A2 (en) 2008-07-31 2009-07-31 Method of preparing a muscadine pomace extract

Publications (1)

Publication Number Publication Date
MX2011001183A true MX2011001183A (es) 2011-03-30

Family

ID=41610969

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011001183A MX2011001183A (es) 2008-07-31 2009-07-31 Metodo para preparar un extracto de begazo de muscadine.

Country Status (7)

Country Link
US (2) US8512771B2 (enExample)
JP (1) JP5851240B2 (enExample)
CN (2) CN102164607B (enExample)
CA (1) CA2732426C (enExample)
MX (1) MX2011001183A (enExample)
MY (1) MY158981A (enExample)
WO (1) WO2010014873A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132162B2 (en) * 2008-07-31 2015-09-15 Shaklee Corporation Muscadine compositions with anti-oxidant activity
CA2732426C (en) * 2008-07-31 2018-05-15 Shaklee Corporation Method of preparing a muscadine pomace extract
US9173916B2 (en) * 2008-07-31 2015-11-03 Shaklee Corporation Method of preparing a muscadine pomace extract
CA2904636C (en) * 2013-03-14 2021-05-04 Shaklee Corporation Method of preparing a muscadine pomace extract
US20160067298A1 (en) * 2014-09-10 2016-03-10 Clark Atlanta University Muscadine grape skin extract as treatment for bone metastatic cancer
US9579618B2 (en) 2015-06-17 2017-02-28 Christos Ritzoulis Emulsifiers from grape processing by-products
ES2644166B1 (es) * 2016-05-24 2018-09-24 Universitat Politécnica de Catalunya Procedimiento para la obtención de un extracto tánico aislado de uva, extracto tánico obtenido y sus usos
CN109641024B (zh) * 2016-07-19 2022-03-25 嘉康利公司 具有低含量缩合鞣质分子的麝香葡萄局部组合物
US20180325804A1 (en) * 2017-05-12 2018-11-15 Shaklee Corporation Topical muscadine formulation for cosmetic use
IT201700081175A1 (it) * 2017-07-18 2019-01-18 Nobil Bio Ricerche Srl Dispositivi implantari rivestiti
CN107691927A (zh) * 2017-11-06 2018-02-16 北京市农林科学院 一种打瓜的综合利用方法
US11103465B2 (en) * 2017-11-22 2021-08-31 Ted's Brain Science, Inc. Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof
CA3054498C (en) * 2017-12-15 2022-08-02 Tsukasa Nagao Health food and cosmetics for increasing the amount of apoptosis cells and decreasing the amount of necrosis cells and a method of manufacturing a sprout-forcing grape seed-derived ingredient for increasing the amount of apoptosis cells and decreasing the amount of necrosis cells
IT202000006493A1 (it) * 2020-03-27 2021-09-27 Ngn Healthcare New Generation Nutraceuticals S R L Integratore alimentare per contrastare la degenerazione maculare legata all’eta’

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2318511A (en) 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water
US6190716B1 (en) 1999-02-17 2001-02-20 Scott O. Galbreath, Jr. Method for preparing a grape derived product
FR2790645B1 (fr) 1999-03-12 2001-06-08 Arkopharma Laboratoires Complement alimentaire et procede de traitement cosmetique a base d' un extrait de raisin riche en polyphenols
CN1137985C (zh) * 2001-02-27 2004-02-11 中法合营王朝葡萄酿酒有限公司 一种干白葡萄酒及其勾兑工艺
JP2002293736A (ja) * 2001-03-30 2002-10-09 Sunstar Inc メーラード反応阻害剤およびそれを含有する組成物
US20040234671A1 (en) * 2003-05-20 2004-11-25 Ector Betty J. Houston Method and system for processing muscadine grape pomace
US20050158376A1 (en) * 2003-10-23 2005-07-21 Sardi William F. Dietary supplement and method of processing same
JP4963670B2 (ja) 2004-04-07 2012-06-27 レスベラトロル パートナーズ， エルエルシー 栄養補助サプリメントおよびそれを処理する方法
US20060024392A1 (en) * 2004-04-20 2006-02-02 The University Of Maryland Compositions and methods for enhancing the effectiveness of a chemotherapeutic agent
US20060121137A1 (en) 2004-12-07 2006-06-08 Hartle Diane K Muscadine grape pomace in the treatment of intestinal inflammation
US8182849B2 (en) 2005-02-23 2012-05-22 Otsuka Pharmaceutical Co., Ltd. Fermented tea beverage and tea beverage
WO2006113700A1 (en) * 2005-04-16 2006-10-26 Unitel Technologies, Inc. Concentrated polyphenolic product and process for making the same
US20060277887A1 (en) * 2005-05-31 2006-12-14 Nutragon, Llc Method for processing organic plant matter into dry powder, oil and juice products
CN1698733A (zh) 2005-06-02 2005-11-23 陕西爱波卓科技有限责任公司 一种含多种抗氧化剂及抗氧化剂促进剂的抗氧化组合物
ES2542713T3 (es) 2005-09-28 2015-08-10 Constellation Brands, Inc. Extracto de uva, suplemento en la dieta del mismo y procedimiento de preparación
JP2009521523A (ja) 2005-12-27 2009-06-04 ジュビラント・オルガノシス・リミテッド 口中溶解性医薬組成物およびその製造方法
US8017147B2 (en) 2008-04-07 2011-09-13 Mazed Mohammad A Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance
KR20100014799A (ko) 2007-01-17 2010-02-11 엔베쎄 뉴트라쇠틱 비지니스 컨썰팅 과일 및 야채를 함유하는 항산화 음식조성물, 그 제조 방법 및 용도
WO2008144019A2 (en) 2007-05-18 2008-11-27 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Suppression of allergic inflammation by ascaris heme-binding protein (hbp)
US20090176718A1 (en) 2007-10-31 2009-07-09 David Ribnicky Berry Preparations For Treatment Of Diabetes And Metabolic Syndrome
US9173916B2 (en) * 2008-07-31 2015-11-03 Shaklee Corporation Method of preparing a muscadine pomace extract
CA2732426C (en) * 2008-07-31 2018-05-15 Shaklee Corporation Method of preparing a muscadine pomace extract
CA2732306C (en) * 2008-07-31 2017-02-28 Shaklee Corporation Muscadine compositions with improved anti-oxidant activity
US9132162B2 (en) * 2008-07-31 2015-09-15 Shaklee Corporation Muscadine compositions with anti-oxidant activity
US8114445B2 (en) 2008-11-07 2012-02-14 Reliv International Inc. Dietary supplement for promoting wellness and weight loss and methods of administering the same
US8173181B2 (en) 2009-11-09 2012-05-08 Bio-Engineered Supplements & Nutrition, Inc. Method and composition for improved anabolism

Also Published As

Publication number Publication date
US9421189B2 (en) 2016-08-23
JP2011529909A (ja) 2011-12-15
WO2010014873A3 (en) 2010-05-06
JP5851240B2 (ja) 2016-02-03
CN103623135B (zh) 2015-12-09
US8512771B2 (en) 2013-08-20
CA2732426C (en) 2018-05-15
MY158981A (en) 2016-11-30
US20130303603A1 (en) 2013-11-14
US20110177183A1 (en) 2011-07-21
CN102164607A (zh) 2011-08-24
CN103623135A (zh) 2014-03-12
CN102164607B (zh) 2013-04-24
CA2732426A1 (en) 2010-02-04
WO2010014873A2 (en) 2010-02-04
HK1190328A1 (zh) 2014-07-04

Similar Documents

Publication Publication Date Title
CA2732306C (en) Muscadine compositions with improved anti-oxidant activity
CA2732426C (en) Method of preparing a muscadine pomace extract
US20180042862A1 (en) Antioxidant dietary supplement compositions and methods for maintaining healthy skin
US9132162B2 (en) Muscadine compositions with anti-oxidant activity
EP2051595B1 (en) Stable and bioavailable compositions of isomers of carotenoids for skin and hair
US9173916B2 (en) Method of preparing a muscadine pomace extract
CA2904636C (en) Method of preparing a muscadine pomace extract
TWI448250B (zh) 具有改良的抗氧化劑活性的麝香葡萄組成物
HK1190328B (en) Method of preparing a muscadine pomace extract
HK40030218A (en) Composition for promoting expression of aquaporin 3, and use thereof
CN111182798A (zh) 水通道蛋白3表达促进用组合物及其使用

Legal Events

Date Code Title Description
FG Grant or registration